Urology · Orlando, FL
NPI
1255329439
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
41 W Kaley St
Orlando, FL, 32806
Phone (407) 843-6645
Groups this clinician bills Medicare through
Medicare paid, 2024
$258K
10,980 services
Medicare patients, 2024
599
Average age 76
Drug cost, 2024
$328K
2,637 prescriptions
Company payments, 2025
$1,097
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marshall S Melcer was code 81002 (clinical chemistry), 1,346 times for 570 patients. In total Marshall S Melcer billed 10,980 services in 71 codes, and Medicare paid $258K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 1,346 | 570 | $3.37 | $4,529 |
| 99214 Office E&M - Established | Office | 1,153 | 524 | $95.13 | $110K |
| 51798 Ultrasound - Nonspecific | Office | 834 | 438 | $8.39 | $6,999 |
| 51741 Test - Miscellaneous | Office | 608 | 327 | $10.50 | $6,383 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 581 | 387 | $13.72 | $7,974 |
| 86386 Immunoassay | Office | 224 | 159 | $21.34 | $4,780 |
| 52000 Cystourethroscopy | Office | 164 | 131 | $184.98 | $30K |
| 99213 Office E&M - Established | Office | 147 | 121 | $68.54 | $10K |
| 74018 Standard X-ray | Office | 138 | 95 | $22.59 | $3,118 |
| 99204 Office E&M - New | Office | 110 | 110 | $126.28 | $14K |
| 36415 Venipuncture Blood Collection | Office | 76 | 62 | $7.84 | $596 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 72 | 70 | $24.98 | $1,799 |
| 99211 Office E&M - Established | Office | 37 | 18 | $17.43 | $645 |
| 52310 Calculus Removal - Urinary | Office | 18 | 14 | $263.67 | $4,746 |
By year: 2022 $205K for 12,699 services; 2023 $221K for 15,015 services; 2024 $258K for 10,980 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,346 | 570 | $3.37 | $4,529 |
| 86386 Immunoassay | 224 | 159 | $21.34 | $4,780 |
| 36415 Venipuncture Blood Collection | 76 | 62 | $7.84 | $596 |
Medicare prescription drug claims, 2024
In 2024, the drug Marshall S Melcer prescribed most often to Medicare patients was Finasteride, with 611 prescriptions and refills. In total Marshall S Melcer wrote 2,637 Medicare prescriptions that cost $328K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 611 | 1,819 | 191 | $7,047 |
| Tamsulosin Hcl Generic | 437 | 1,248 | 147 | $5,567 |
| Silodosin Generic | 340 | 850 | 116 | $32K |
| Dutasteride Generic | 250 | 716 | 82 | $7,942 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 148 | 418 | 47 | $3,404 |
| Ciprofloxacin Hcl Generic | 97 | 103 | 73 | $1,167 |
| Myrbetriq Mirabegron | 90 | 195 | 24 | $88K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 70 | 74 | 43 | $1,152 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 59 | 60 | 43 | $576 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 57 | 147 | 14 | $836 |
| Doxycycline Hyclate Generic | 54 | 55 | 46 | $963 |
| Orgovyx Relugolix | 45 | 45 | Under 11 | $121K |
| Testosterone Generic | 38 | 77 | 13 | $9,102 |
| Solifenacin Succinate Generic | 37 | 108 | 13 | $2,207 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 47 | 24 | $277 |
Brand drugs: 196 claims; generic drugs: 2,441 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marshall S Melcer $1,097 ($1,097 in general payments such as food, travel and fees) from 18 companies. The largest payer was Endo USA, Inc. with $187.
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 8 | $187 |
| Ferring Pharmaceuticals Inc. | 9 | $181 |
| Myriad Genetic Laboratories, Inc. MYGN | 5 | $132 |
| Pfizer Inc. PFE | 6 | $111 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $80.58 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $72.98 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $63.82 |
| Janssen Biotech, Inc. JNJ | 2 | $33.69 |
| Dendreon Pharmaceuticals LLC | 1 | $33.67 |
| Coloplast Corp | 1 | $27.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.